Abstract
The effect of nordihydroguaiaretic acid (NDGA) on Ca2+ signaling in human hepatoma cells (HA22/VGH) has been investigated. NDGA (5-50 μM) increased [Ca2+]i concentration-dependently. The [Ca2+]i increase comprised an initial rise and an elevated phase over a time period of 4 min. Removal of extracellular Ca2+ reduced 10-50 μM NDGA induced [Ca2+]i signals by 45±5%. Consistently, the 50 μM NDGA-induced [Ca2+]i increase in Ca2+-containing medium was reduced by 41±2% by 10 μM of La3+, nifedipine or verapamil. In Ca2+-free medium, pretreatment with 20 μM NDGA for 6 min abolished the [Ca2+]i increase induced by the endoplasmic reticulum Ca2+ pump inhibitor thapsigargin (1 μM). Conversely, 20 μM NDGA failed to increase [Ca2+]i after 1 μM thapsigargin had depleted the endoplasmic reticulum Ca2+ store. Inhibition of phospholipase C with 2 μM U73122 had little effect on 20 μM NDGA-induced Ca2+ release. Several other lipoxygenase inhibitors had no effect on basal [Ca2+]i. Together, the data suggest that NDGA increased [Ca2+]i in hepatocytes in a lipoxygenase-independent manner, by releasing Ca2+ from the endoplasmic reticulum and causing Ca2+ influx.
| Original language | English |
|---|---|
| Pages (from-to) | 485-490 |
| Number of pages | 6 |
| Journal | Toxicology in Vitro |
| Volume | 16 |
| Issue number | 5 |
| DOIs | |
| State | Published - 10 2002 |
| Externally published | Yes |
Keywords
- Ca signaling
- Ca stores
- Fura-2
- HA22/VGH cells
- Hepatocytes
- Nordihydroguaiaretic acid (NDGA)